• About Sanoculis
    Sanoculis Ltd. is a medical device start-up company which develops an alternative new surgical procedure for the treatment of Glaucoma. This procedure is expected to be safe, effective and simple to perform and intends to supplement currently available surgical solutions in a multi-billion international market.

    Sanoculis was established in 2012, originally funded by the Alfred Mann Institute at the Technion, Israel and currently funded by a private group of investors.

    Minimally Invasive Micro Sclerostomy (MIMS) is a surgical procedure which consists of a single-patient use sterile tool and a multi-use external machine. In the course of the surgery, a sclero-corneal drainage channel is created in order to reduce intraocular pressure (IOP), one which is comparable to existing surgical techniques. The channel created with the MIMS is designed to obtain a long-lasting controlled fluid flow along with minor related complications.

    The procedure is minimally invasive, and apparently simpler and faster than existing methods.